Taitacept
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Taitacept, covering 2024-11-20 to 2024-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis [Phase 2]